Results from the remdesivir COVID-19 trial are out, and it’s good news

Enlarge / Treatment with the antiviral drug remdesivir shortens the recovery time for patients with COVID-19. digicomphoto/Getty Images On Friday, some good news in the fight against SARS-CoV-2 was published in The New England Journal of Medicine. The antiviral drug remdesivir—originally developed as a potential treatment for Ebola—was shown to shorten recovery time for patients …

Results from the remdesivir COVID-19 trial are out, and it’s good news Read More »